Glycogen synthase kinase 3 beta inhibits microRNA-183-96-182 cluster via the β-Catenin/TCF/LEF-1 pathway in gastric cancer cells

Nucleic Acids Research

Volumn 42, Issue 5, 2014, Pages 2988-2998

  Tang, Xiaoli ^a   Zheng, Dong ^a,b   Hu, Ping ^c   Zeng, Zongyue ^a,c   Li, Ming ^a   Tucker, Lynne ^a   Monahan, Renee ^a   Resnick, Murray B ^a   Liu, Manran ^c   Ramratnam, Bharat ^a,b  

^a BROWN UNIVERSITY   (United States)

^b NORTHEAST FORESTRY UNIVERSITY   (China)

^c CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; GLYCOGEN SYNTHASE KINASE 3BETA; LYMPHOID ENHANCER FACTOR 1; MICRORNA; MICRORNA 182; MICRORNA 183; MICRORNA 96; RNA ANTIBODY; SMALL INTERFERING RNA; T CELL FACTOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CELL MIGRATION; CELL NUCLEUS; CELL PROLIFERATION; CELL STRAIN AGS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; EMBRYO; ENZYME ACTIVITY; FIBROBLAST; GENE CLUSTER; GENE EXPRESSION; GENE INACTIVATION; GENETIC REGULATION; HUMAN; HUMAN TISSUE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; STOMACH CANCER; TISSUE LEVEL; TRANSCRIPTION INITIATION;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; BETA CATENIN; CELL NUCLEUS; CELLS, CULTURED; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOGEN SYNTHASE KINASE 3; HUMANS; LYMPHOID ENHANCER-BINDING FACTOR 1; MICE; MICRORNAS; PHENOTYPE; PROMOTER REGIONS, GENETIC; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS; TCF TRANSCRIPTION FACTORS; TRANSCRIPTIONAL ACTIVATION;

EID: 84896919067     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkt1275     Document Type: Article

References (42)

1. Hoeflich, K.P., Luo, J., Rubie, E.A., Tsao, M.S., Jin, O. and Woodgett, J.R. (2000) Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation. Nature, 406, 86-90. (Pubitemid 30460216
2. Rubinfeld, B., Albert, I., Porfiri, E., Fiol, C., Munemitsu, S. and Polakis, P. (1996) Binding of GSK3beta to the APC-Beta-catenin complex and regulation of complex assembly. Science, 272, 1023-1026. (Pubitemid 26259322
3. Behrens, J., von Kries, J.P., Kühl, M., Bruhn, L., Wedlich, D., Grosschedl, R. and Birchmeier, W. (1996) Functional interaction of beta-catenin with the transcription factor LEF-1. Nature, 382, 638-642.
4. Behrens, J., Jerchow, B.A., Würtele, M., Grimm, J., Asbrand, C., Wirtz, R., Kühl, M., Wedlich, D. and Birchmeier, W. (1998) Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta. Science, 280, 596-599.
5. Aberle, H., Bauer, A., Stappert, J., Kispert, A. and Kemler, R. (1997) beta-catenin is a target for the ubiquitin-proteasome pathway. EMBO J., 16, 3797-3804.
6. He, T.C., Sparks, A.B., Rago, C., Hermeking, H., Zawel, L., da Costa, L.T., Morin, P.J., Vogelstein, B. and Kinzler, K.W. (1998) Identification of c-MYC as a target of the APC pathway. Science, 281, 1509-1512. (Pubitemid 28425575
7. Mann, B., Gelos, M., Siedow, A., Hanski, M.L., Gratchev, A., Ilyas, M., Bodmer, W.F., Moyer, M.P., Riecken, E.O., Buhr, H.J. et al. (1999) Target genes of beta-catenin-T cell-factor/lymphoidenhancer-factor signaling in human colorectal carcinomas. Proc. Natl Acad. Sci. USA, 96, 1603-1608.
8. Tetsu, O. and McCormick, F. (1999) Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature, 398, 422-426. (Pubitemid 29180374
9. Tang, X., Zhang, Y., Tucker, L. and Ramratnam, B. (2010) Phosphorylation of the RNase III enzyme Drosha at Serine300 or Serine302 is required for its nuclear localization. Nucleic Acids Res., 38, 6610-6619.
10. Tang, X., Li, M., Tucker, L. and Ramratnam, B. (2011) Glycogen Synthase Kinase 3 beta (GSK3b) phosphorylates the RNAase III enzyme Drosha at S300 and S302. PLoS One, 6, e20391.
11. Lee, R.C., Feinbaum, R.L. and Ambros, V. (1993) The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell, 75, 843-854. (Pubitemid 24014542
12. Han, J., Lee, Y., Yeom, K.H., Kim, Y.K., Jin, H. and Kim, V.N. (2004) The Drosha-DGCR8 complex in primary microRNA processing. Genes Dev., 18, 3016-3027. (Pubitemid 39658171
13. Lee, Y., Ahn, C., Han, J., Choi, H., Kim, J., Yim, J., Lee, J., Provost, P., Ra dmark, O., Kim, S. et al. (2003) The nuclear RNase III Drosha initiates microRNA processing. Nature, 425, 415-419.
14. Han, J., Lee, Y., Yeom, K.H., Nam, J.W., Heo, I., Rhee, J.K., Sohn, S.Y., Cho, Y., Zhang, B.T. and Kim, V.N. (2006) Molecular basis for the recognition of primary microRNAs by the.complex. Cell, 125, 887-901. (Pubitemid 43810154
15. Lee, Y., Kim, M., Han, J., Yeom, K.H., Lee, S., Baek, S.H. and Kim, V.N. (2004) MicroRNA genes are transcribed by RNA polymerase II. EMBO J., 23, 4051-4060. (Pubitemid 39472426
16. Borchert, G.M., Lanier, W. and Davidson, B.L. (2006) RNA polymerase III transcribes human microRNAs. Nat. Struct. Mol. Biol., 13, 1097-1101.
17. Landthaler, M., Yalcin, A. and Tuschl, T. (2004) The human DiGeorge syndrome critical region gene 8 and its D. melanogaster homolog are required for miRNA biogenesis. Curr. Biol., 14, 2162-2167.
18. Lee, Y., Han, J., Yeom, K.H., Jin, H. and Kim, V.N. (2006) Drosha in primary microRNA processing. Cold Spring Harb. Symp. Quant. Biol., 71, 51-57.
19. Winter, J., Jung, S., Keller, S., Gregory, R.I. and Diederichs, S. (2009) Many roads to maturity: MicroRNA biogenesis pathways and their regulation. Nat. Cell Biol., 11, 228-234.
20. Kim, V.N., Han, J. and Siomi, M.C. (2009) Biogenesis of small RNAs in animals. Nat. Rev. Mol. Cell Biol., 10, 126-139.
21. Gregory, R.I. and Shiekhattar, R. (2005) MicroRNA biogenesis and cancer. Cancer Res., 65, 3509-3512. (Pubitemid 40616320
22. Ma, L., Teruya-Feldstein, J. and Weinberg, R.A. (2007) Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature, 449, 682-688. (Pubitemid 47552092
23. Zhang, W., Dahlberg, J.E. and Tam, W. (2007) MicroRNAs in tumorigenesis: A primer. Am. J. Pathol., 171, 728-738.
24. John, B., Enright, A.J., Aravin, A., Tuschl, T., Sander, C. and Marks, D.S. (2004) Human microRNA targets. PLoS Biol., 2, e363.
25. Leung, A.K. and Sharp, P.A. (2007) microRNAs: A safeguard against turmoil? Cell, 130, 581-585.
26. Lumayag, S., Haldin, C.E., Corbett, N.J., Wahlin, K.J., Cowan, C., Turturro, S., Larsen, P.E., Kovacs, B., Witmer, P.D., Valle, D. et al. (2013) Inactivation of the microRNA-183/96/182 cluster results in syndromic retinal degeneration. Proc. Natl Acad. Sci. USA, 110, E507-E516.
27. Ueno, K., Hirata, H., Shahryari, V., Deng, G., Tanaka, Y., Tabatabai, Z.L., Hinoda, Y. and Dahiya, R. (2013) microRNA-183 is an oncogene targeting Dkk-3 and SMAD4 in prostate cancer. Br. J. Cancer, 108, 1659-1667.
28. Xu, D., He, X., Chang, Y., Xu, C., Jiang, X., Sun, S. and Lin, J. (2013) Inhibition of miR-96 expression reduces cell proliferation and clonogenicity of HepG2 hepatoma cells. Oncol. Rep., 29, 653-661.
29. Chiang, C.H., Hou, M.F. and Hung, W.C. (2013) Up-regulation of miR-182 by b-catenin in breast cancer increases tumorigenicity and invasiveness by targeting the matrix metalloproteinase inhibitor RECK. Biochim. Biophys. Acta, 1830, 3067-3076.
30. Zhang, Q.H., Sun, H.M., Zheng, R.Z., Li, Y.C., Zhang, Q., Cheng, P., Tang, Z.H. and Huang, F. (2013) Meta-Analysis of microRNA-183 family expression in human cancer studies comparing cancer tissues with noncancerous tissues. Gene, 527, 26-32.
31. Kong, W.Q., Bai, R., Liu, T., Cai, C.L., Li, X. and Tang, H. (2012) MicroRNA-182 targets cAMP-responsive element-binding protein 1 and suppresses cell growth in human gastric adenocarcinoma. FEBS J., 279, 1252-1260.
32. Li, X., Luo, F., Li, Q., Xu, M., Feng, D., Zhang, G. and Wu, W. (2011) Identification of new aberrantly expressed miRNAs in intestinal-Type gastric cancer and its clinical significance. Oncol. Rep., 26, 1431-1439.
33. Zeng, C., Wang, R., Li, D., Lin, X.J., Wei, Q.K., Yuan, Y., Wang, Q., Chen, W. and Zhuang, S.M. (2010) A novel GSK-3 beta-C/EBP alpha-miR-122-insulin- like growth factor 1 receptor regulatory circuitry in human hepatocellular carcinoma. Hepatology, 52, 1702-1712.
34. Ji, J., Yamashita, T. and Wang, X.W. (2011) Wnt/beta-catenin signaling activates microRNA-181 expression in hepatocellular carcinoma. Cell Biosci., 1, 4.
35. Zhang, J., Han, C. and Wu, T. (2012) MicroRNA-26a promotes cholangiocarcinoma growth by activating b-catenin. Gastroenterology, 143, 246-256.
36. Tang, X., Gao, J.S., Guan, Y.J., McLane, K.E., Yuan, Z.L., Ramratnam, B. and Chin, Y.E. (2007) Acetylation-dependent signal transduction for type I interferon receptor. Cell, 131, 93-105. (Pubitemid 47498527
37. Klaus, A. and Birchmeier, W. (2008) Wnt signaling and its impact on development and cancer. Nat. Rev. Cancer, 8, 387-398.
38. Radulescu, S., Ridgway, R.A., Cordero, J., Athineos, D., Salgueiro, P., Poulsom, R., Neumann, J., Jung, A., Patel, S., Woodgett, J. et al. (2013) Acute WNT signalling activation perturbs differentiation within the adult stomach and rapidly leads to tumour formation. Oncogene, 32, 2048-2057.
39. Bernatik, O., Ganji, R.S., Dijksterhuis, J.P., Konik, P., Cervenka, I., Polonio, T., Krejci, P., Schulte, G. and Bryja, V. (2011) Sequential activation and inactivation of Dishevelled in the Wnt/beta-catenin pathway by casein kinases. J. Biol. Chem., 286, 10396-10410.
40. Bryja, V., Schambony, A., Cajá nek, L., Dominguez, I., Arenas, E. and Schulte, G. (2008) Beta-Arrestin and casein kinase 1/2 define distinct branches of non-canonical WNT signalling pathways. EMBO Rep., 9, 1244-1250.
41. Anastas, J.N. and Moon, R.T. (2013) WNT signalling pathways as therapeutic targets in cancer. Nat. Rev. Cancer, 13, 11-26.
42. Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Abovans, V., Abraham, J., Adair, T., Aggarwal, R., Ahn, S.Y. et al. (2012) Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the global burden of disease study 2010. Lancet, 380, 2095-2128.